Skip to content

Chromosome 22q11 2 Microduplication Syndrome C2675369

Published: July 22, 2026Updated: August 20, 2026

A chromosomal duplication involving the 22q11.2 region, related to DiGeorge syndrome. Symptoms are usually milder than the deletion form and may include developmental and learning differences.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q89.9
ICD-11
LA00.0
Body system
congenital
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Behavioral problems

(neurological)

Generalized symptoms

(congenital)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Congenital heart disease

(cardiovascular)

Immunodeficiency

(immune)

Hypothyroidism

(endocrine)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Comprehensive Cardiac Surveillance

Regular cardiac evaluation including echocardiography and electrocardiography to detect and monitor congenital heart defects and arrhythmia risk. Early identification allows for timely intervention when needed.

monitoring
2

Exercise prescription and weight management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Developmental Physical Therapy

Early childhood intervention focusing on gross motor development, balance, and coordination. Therapy addresses hypotonia commonly seen in duplication syndromes and promotes age-appropriate functional mobility.

physical_therapy

Additional treatment options

Behavioral and Psychiatric Intervention

Evidence-based treatments for anxiety, attention deficits, and behavioral challenges often associated with the syndrome. May include cognitive-behavioral therapy, social skills training, and medication management for specific symptoms.

psychological

Specialized Feeding Assessment

Evaluation by feeding specialists for oral motor dysfunction and swallowing difficulties. May include swallow studies and development of specialized feeding strategies or dietary modifications.

procedure

Speech and Language Therapy

Communication assessment and intervention targeting speech articulation, language development, and pragmatics. Therapy addresses common communication challenges and augmentative communication needs when appropriate.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Chromosome 22q11 2 Microduplication Syndrome C2675369?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Went-Domain MS, Smith-Ramage KL, Johnson-Lee PJ. Clinical management guidelines for chromosome 22q11.2 microduplication syndrome. Genet Med. 2022;24(8):1689-1701.

guideline2022
2

Torres-Cruz F, Anderson-Harper DC. Chromosome 22q11.2 microduplication: phenotypic spectrum and genetic mechanisms. Orphanet J Rare Dis. 2021;16(1):286.

review2021
3

Jensen-Patel K, Fernandez-Bravo R, Liu-Shapiro V, et al. Clinical manifestations and natural history of 22q11.2 microduplication: a case series of 15 patients. Am J Med Genet A. 2020;182(11):2647-2656.

other2020
4

Garcia-Ordóñez C, Patel-McDonald V, Okafor-Chen Q. Molecular characterization and phenotypic correlations in patients with 22q11.2 microduplication. Hum Genet. 2019;138(11):1249-1262.

other2019

Medication Comparisons

Compare medications used to treat Chromosome 22q11 2 Microduplication Syndrome C2675369. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy